| 报告期 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、经营活动产生的现金流量: | | | | |
| 销售商品、提供劳务收到的现金 | 288,284,812.97 | 207,067,620.29 | 106,971,791.14 | 414,094,640.8 |
| 收到的税费返还 | 29,528,243.74 | 19,390,734.38 | 11,475,911.34 | 46,754,707.31 |
| 收到其他与经营活动有关的现金 | 8,062,738.11 | 3,624,405.43 | 5,604,410.94 | 19,933,716.73 |
| 经营活动现金流入小计 | 325,875,794.82 | 230,082,760.1 | 124,052,113.42 | 480,783,064.84 |
| 购买商品、接受劳务支付的现金 | 194,940,717.58 | 140,059,496.13 | 71,705,545.17 | 274,030,963.37 |
| 支付给职工以及为职工支付的现金 | 92,409,716.02 | 62,282,220.04 | 30,907,493.52 | 127,021,418.04 |
| 支付的各项税费 | 32,143,448.48 | 21,415,332.07 | 11,990,799.96 | 49,756,416.3 |
| 支付其他与经营活动有关的现金 | 4,914,063.4 | 2,578,714.08 | 2,821,725.04 | 37,660,522.14 |
| 经营活动现金流出小计 | 324,407,945.48 | 226,335,762.32 | 117,425,563.69 | 488,469,319.85 |
| 经营活动产生的现金流量净额 | 1,467,849.34 | 3,746,997.78 | 6,626,549.73 | -7,686,255.01 |
| 二、投资活动产生的现金流量: | | | | |
| 处置固定资产、无形资产和其他长期资产收回的现金净额 | - | - | - | 134,510 |
| 投资活动现金流入的平衡项目 | - | - | - | 0 |
| 投资活动现金流入小计 | - | - | - | 134,510 |
| 购建固定资产、无形资产和其他长期资产支付的现金 | 385,733.6 | 233,233.6 | 55,000 | 179,705 |
| 投资活动现金流出小计 | 385,733.6 | 233,233.6 | 55,000 | 179,705 |
| 投资活动产生的现金流量净额 | -385,733.6 | -233,233.6 | -55,000 | -45,195 |
| 三、筹资活动产生的现金流量: | | | | |
| 偿还债务支付的现金 | - | - | - | 1,277,884.46 |
| 分配股利、利润或偿付利息支付的现金 | 75,708.19 | 59,931.91 | 26,497.51 | - |
| 筹资活动现金流出小计 | 75,708.19 | 59,931.91 | 26,497.51 | 1,277,884.46 |
| 筹资活动产生的现金流量净额 | -75,708.19 | -59,931.91 | -26,497.51 | -1,277,884.46 |
| 四、汇率变动对现金及现金等价物的影响 | 1,268,148.47 | 1,252,128.36 | 861,210.96 | 3,464,056.19 |
| 五、现金及现金等价物净增加额 | 2,274,556.02 | 4,705,960.63 | 7,406,263.18 | -5,545,278.28 |
| 加:期初现金及现金等价物余额 | 1,297,122.25 | 1,297,122.25 | 1,517,370.68 | 6,842,400.53 |
| 期末现金及现金等价物余额 | 3,571,678.27 | 6,003,082.88 | 8,923,633.86 | 1,297,122.25 |
| 补充资料: | | | | |
| 净利润 | - | -95,725,661.73 | - | -577,487,853.7 |
| 资产减值准备 | - | 22,462,827.34 | - | 16,437,145.45 |
| 固定资产和投资性房地产折旧 | - | 26,437,468.81 | - | 65,808,959.48 |
| 其中:固定资产折旧、油气资产折耗、生产性生物资产折旧 | - | 26,437,468.81 | - | 65,808,959.48 |
| 无形资产摊销 | - | 2,526,958.14 | - | 5,076,416.51 |
| 固定资产报废损失 | - | - | - | -188,284.64 |
| 公允价值变动损失 | - | - | - | 362,498,550.76 |
| 财务费用 | - | 19,473,525.39 | - | 61,954,504.17 |
| 递延所得税 | - | -9,144,110.54 | - | 10,589,847.3 |
| 其中:递延所得税资产减少 | - | -9,144,110.54 | - | 10,830,139.36 |
| 递延所得税负债增加 | - | - | - | -240,292.06 |
| 存货的减少 | - | -27,580,454.4 | - | -1,454,545.97 |
| 经营性应收项目的减少 | - | 26,426,429.34 | - | -31,099,540.67 |
| 经营性应付项目的增加 | - | 38,870,015.43 | - | 55,768,156.29 |
| 其他 | - | - | - | 24,054,254.59 |
| 现金的期末余额 | - | 6,003,082.88 | - | 1,297,122.25 |
| 减:现金的期初余额 | - | 1,297,122.25 | - | 6,842,400.53 |
| 现金及现金等价物的净增加额 | - | 4,705,960.63 | - | -5,545,278.28 |
| 公告日期 | 2025-10-30 | 2025-08-29 | 2025-04-30 | 2025-04-29 |
| 审计意见(境内) | | | | 保留意见 |